Sheng Fu, MD

My turn. #FU2024

Do you love hemodynamics & RHCs? @ShengFuMD @chakri0012 & I do too! BUT, hemodynamic evaluation of donor hearts may not be helpful. Abnormal hemos, particularly high filling pressures, did not correlate w/ post-transplant outcomes in our UNOS analysis. onlinejcf.com/article/S1071-…

My latest on Stop and Think There may be a BIG NEW development in cardiology. I describe it here. See what you think> johnmandrola.substack.com/p/big-changes-…

Heteroscedasticity is such a @Brian_Houston12 word.

#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease. #ESCCongress

Finally an adult.

Some consolation for losing your two favorite fellows @RyanTedfordMD @heartsuccessMD

@RyanTedfordMD @MUSCCardFellows @MUSChealth @hopkinsheart @dkassjhu @DLMann_MD @Brian_Houston12 @HajjJennifer @mevansMD @KaczmarekMD @MollySilkowski @skyazim @DhariniRamu @AmandaCelia12 @GregJacksonMD This is feedback.

Outstanding talk today by @MUSCCardFellows AHFTC fellow @ShengFuMD on cardiomyocyte biology, neurohormones, ventricular remodeling, and pharmacogenomics. Including some classic @MUSChealth @hopkinsheart studies! @dkassjhu @DLMann_MD “This is teaching”

@AdnanKhalifMD @MattLanderMD @manreetkanwar @ranga1949 Excuse me. It's both armpits.

@MattLanderMD @manreetkanwar @ranga1949 haha I once had a co-fellow that also used an armpit to determine warm or dry for hemodynamic profiling. So, why not? @ShengFuMD

Is pitting edema to your armpits bad? #justheartfailurethings #successnotfailure @manreetkanwar @AdnanKhalifMD @ranga1949

Read our News and Views by @RyanTedfordMD and colleagues @MUSChealth for an insightful discussion into SGLT-2 inhibitors for treatment of #heartfailure with preserved ejection fraction. nature.com/articles/s4159…

Congrats to the PRESERVED-HF team for their important @NatureMedicine study of #SGLT2I in @HFpEF. @MkosiborodMD @MichaelNassifMD @manreetkanwar Check out our News & Views endpoint discussion led by @MUSChealth AHFTC fellow @ShengFuMD. @LitwinSheldon rdcu.be/cBhlf

Proud to announce the publication of CAPITAL DOREMI in @NEJM - a comparison of milrinone and dobutamine in cardiogenic shock. Contrary to the hypothesis milrinone was not superior to dobutamine in this randomized double blind comparison. nejm.org/doi/full/10.10…

@NamitaJMD @manreetkanwar @RyanTedfordMD @rcogswell_umn Yes please! But also, pretty sure one of us is in an more attractive place to visit 😉

@manreetkanwar @RyanTedfordMD @rcogswell_umn @ShengFuMD @manreetkanwar @RyanTedfordMD @rcogswell_umn @ShengFuMD I miss you come visit me!! But also can we all collab?!

@manreetkanwar @RyanTedfordMD @rcogswell_umn @NamitaJMD Can't imagine I wouldn't be!

@AdnanKhalifMD @FKatchiMD @DavidLBrownMD @MKIttlesonMD @manreetkanwar @RyanTedfordMD @rcogswell_umn Pretty sure they've fallen off the preload dependent portion of the curve. Also have concerns about the mechanical stunning after cardioversion in decompensated HF.

Arguments from CICU report today. Is decompensated HF a preload dependent or independent state? And how does that apply to understanding benefit of DCCV in patients with AF and HF @FKatchiMD @DavidLBrownMD @MKIttlesonMD @ShengFuMD @manreetkanwar @RyanTedfordMD @rcogswell_umn

Browns fans looking at the score 😂 (via @MUTGuru)

Trivia: What's wrong with this patient?😉 #WhyCMR #4DFlow #CardioTwitter @SCMRorg @scmrchd @escardio @ImagenCardiaca @ArterysInc